EP3464283A1 - Procédé de préparation de composés hétérocycliques - Google Patents

Procédé de préparation de composés hétérocycliques

Info

Publication number
EP3464283A1
EP3464283A1 EP17724598.2A EP17724598A EP3464283A1 EP 3464283 A1 EP3464283 A1 EP 3464283A1 EP 17724598 A EP17724598 A EP 17724598A EP 3464283 A1 EP3464283 A1 EP 3464283A1
Authority
EP
European Patent Office
Prior art keywords
formula
alkyl group
group
alkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17724598.2A
Other languages
German (de)
English (en)
Inventor
Stefan Antons
Martin Littmann
Joerg Schulz
Wahed Ahmed Moradi
Thomas Geller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Publication of EP3464283A1 publication Critical patent/EP3464283A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the present invention relates to a novel process for the preparation of known heterocyclic compounds of the formula I.
  • EP 1024140 describes the reaction of compounds of the formula (II)
  • One aspect of the present invention relates to a process for the preparation of compounds of the formula (I)
  • R 1 represents a hydrogen atom or an alkyl group, preferably a C 1 -C 4 -alkyl group,
  • A is an ethylene group which may be substituted by alkyl, preferably C 1 -C 4 -alkyl, or a trimethylene group which may be substituted by alkyl, preferably C 1 -C 4 -alkyl,
  • X is an oxygen or sulfur atom or the groups
  • - LH or -CH-R 3 in which represents a hydrogen atom or an alkyl group, preferably a C 1 -C 4 alkyl group, and
  • Z denotes an optionally substituted 5- or 6-membered heterocyclic group which contains at least two heteroatoms selected from oxygen, sulfur and nitrogen atoms, or denotes an optionally substituted 3- or 4-pyridyl group, characterized in that compounds of the formula (II )
  • n depending on the counterion (M n + ) can be one or two
  • a phase transfer catalyst preferably an ammonium salt, more preferably a quaternary ammonium salt, with 2 -Chloro-5-chloromethylpyridine.
  • phase transfer catalyst is an ammonium salt of the formula - N-R5 anion
  • R6 wherein R4, R5, R6 is hydrogen or a Ci-Ci 2 alkyl group, or benzyl or alkylbenzyl stand, preferably a Ci-Ci 2 -alkyl group (for clarity, is in -N (-NR4R5R6) "1" the well-known shorthand notation for a methyl group, (-NR4R5R6) "1" is the short notation of (Me-NR4R5R6) + ), and
  • R6 wherein R4, R5, R6 is hydrogen or a Ci-Ci 2 alkyl group, or benzyl or - alkylbenzyl (preferably C 12 - alkylbenzyl) are provided and R7 is a Ci-Ci 2 alkyl group, or - benzyl or alkylbenzyl is , preferably a Ci-Ci 2 alkyl group are, and anion "OH, chloride, bromide, iodide or cyanide is, preferably represents chloride.
  • a preferred embodiment relates to a process according to the invention, in which the organic-soluble quaternary ammonium salt is Aliquat 336 (methyltri-n-octylammonium chloride).
  • a preferred embodiment relates to a process according to the invention in which the solvent is selected from benzene, toluene, xylene, mixtures thereof or hexane, cyclohexane, methylcyclohexane and mixtures thereof.
  • a preferred embodiment relates to a process according to the invention, wherein the solvent is toluene.
  • a preferred embodiment relates to a method according to the invention, wherein M + represents a Na + ion.
  • a preferred embodiment relates to a process according to the invention, wherein the compound of the formula (I) is the compound of the formula (Ia)
  • Ci-C / t-alkyl group is an ethylene group which may be substituted by alkyl, preferably by a Ci-C / t-alkyl, or a trimethylene group, which is alkyl, preferably by a C 1 -C 4 alkyl, may be substituted, represents an oxygen or sulfur atom or the groups or -CH-R 3 , in which
  • R 3 is a hydrogen atom or an alkyl group, preferably a Ci-C / t-alkyl group, and
  • Z is an optionally substituted 5- or 6-membered heterocyclic group containing at least two heteroatoms selected from oxygen, sulfur and nitrogen atoms, or denotes an optionally substituted 3- or 4-pyridyl group, obtained by reacting compounds of the formula (II ) or ammonium, alkali or alkaline earth metal salts of the compound of formula IIa
  • n depending on the counterion (M n + ), can be one or two
  • R 1 is preferably hydrogen or a C 1 -C 3 -alkyl group, more preferably hydrogen;
  • A is preferably an ethylene or trimethylene group, which may each be substituted by a C 1 -C 3 -alkyl group, particularly preferably an ethylene group;
  • X is preferably an oxygen or sulfur atom or the group
  • Z preferably represents a halogenated, 5- or 6-membered heterocyclic group which contains 2 hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen or a halogenated 3- or 4-pyridyl group, more preferably a halogenated thiazolyl or 3-pyridyl group , most preferably 2-chloro-pyrid-5-yl.
  • a very particularly preferred embodiment is directed to a process for preparing a compound of formula (Ia),
  • (IIb) is obtained with an inorganic base and in the presence of a nonpolar aliphatic or aromatic organic solvent, preferably an aromatic hydrocarbon such as toluene or xylene, and by subsequent reaction with 2-chloro-5-chloromethylpyridine, particularly preferably, wherein the reaction in the presence a phase transfer catalyst, or by reacting the compound of formula (IIc)
  • Preferred inorganic bases are ammonium-containing bases, or alkali or alkaline earth metal, particularly preferably NaOH.
  • solvents it is possible to use all nonpolar aliphatic or aromatic solvents or mixtures thereof.
  • aromatic solvents which may be mentioned are: benzene, toluene or xylene or mixtures thereof; Hexane, cyclohexane, methylcycolohexane or mixtures thereof; and mixtures of aliphatic and aromatic solvents. Particularly preferred is toluene.
  • phase transfer catalysts such as
  • R4, R5, R6 is hydrogen or a Ci-Ci 2 alkyl group or benzyl or alkylbenzyl (methyl-N (R4, R5, R6) + anion " , or
  • R6 wherein R4, R5, R6 is hydrogen or a Ci-Ci 2 alkyl group, or benzyl or alkylbenzyl stand and R7 is a Ci-Ci 2 alkyl group, or benzyl or alkylbenzyl group, preferably a C 1 -C 12 - alkyl group stands,
  • anion " for OH, chloride, bromide, iodide, or cyanide, particularly preferably chloride is used.
  • phase transfer catalysts are organic löslische quaternary ammonium salts, particularly preferred quaternary Ci-Ci 2 alkyl ammonium halide salts, particularly preferably C 1 -C 12 - alkyl ammonium chloride salts, such as Aliquat 336 (methyl-tri-n-octylammonium chloride).
  • the process is carried out in a pH range between 6 and 14.
  • the range is preferably between pH 10 and pH 13.
  • the reaction may be carried out at temperatures of 10 ° C to 130 ° C such as 15 ° C to 130 ° C, optionally in vacuo or under pressure. Preference is 40 to 80 ° C.
  • the reaction is conveniently carried out under atmospheric pressure, but it is also possible to work under reduced or elevated pressure.
  • the reaction time is between 0.1 and 12 hours, preferably 1 to 5 hours.
  • the phases can also be separated first.
  • the separation of the organic phase takes place at 50 ° C to 120 ° C, preferably at 40 to 80 ° C.
  • the mixture is then cooled as described above and the precipitated active ingredient is isolated, washed and optionally recrystallized.
  • the compounds of the formula (I) are suitable, for example, for use as insecticides (EP A2 0235 752, EP A2 0259 738).
  • CCMP (2-chloro-5-chloromethylpyridine) were initially charged in 260 g of 1-butanol together with 5 g of Aliquat 336 (methyltri-n-octylammonium chloride) and heated to 70.degree. Within one hour, 250 g of a 29.8% solution of 2-Cyaniminothiazolidin-Na salt (0.5 mol) were metered into water for this purpose. Thereafter, until the complete conversion of Cyaniminothiazolidins was stirred. The mixture was then cooled to 10 ° C and filtered.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)

Abstract

La présente invention concerne un procédé de préparation de composés de formule (I) dans laquelle R1, A, X et Z ont les correspondances indiquées dans la description, par conversion de composés de formule (II) ou de leurs sels avec de la 2-chlor-5-chlorméthylpyridine dans un solvant aromatique ou aliphatique apolaire en présence d'un catalyseur de transfert de phase.
EP17724598.2A 2016-06-06 2017-05-26 Procédé de préparation de composés hétérocycliques Withdrawn EP3464283A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16173126 2016-06-06
PCT/EP2017/062731 WO2017211594A1 (fr) 2016-06-06 2017-05-26 Procédé de préparation de composés hétérocycliques

Publications (1)

Publication Number Publication Date
EP3464283A1 true EP3464283A1 (fr) 2019-04-10

Family

ID=56132768

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17724598.2A Withdrawn EP3464283A1 (fr) 2016-06-06 2017-05-26 Procédé de préparation de composés hétérocycliques

Country Status (10)

Country Link
US (1) US11161840B2 (fr)
EP (1) EP3464283A1 (fr)
JP (1) JP6946354B2 (fr)
KR (1) KR102380911B1 (fr)
CN (1) CN109311866B (fr)
BR (1) BR112018075237B1 (fr)
IL (1) IL263091B (fr)
MX (1) MX2018015178A (fr)
TW (1) TWI750181B (fr)
WO (1) WO2017211594A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23283A (en) 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
JPH0717621B2 (ja) * 1986-03-07 1995-03-01 日本バイエルアグロケム株式会社 新規ヘテロ環式化合物
JPH07121909B2 (ja) 1986-09-10 1995-12-25 日本バイエルアグロケム株式会社 新規複素環式化合物及び殺虫剤
KR0143512B1 (ko) * 1994-06-28 1998-07-15 한경우 배양된 영지버섯 균사체로부터의 면역활성물질의 추출정제방법 및 그로부터 추출된 면역활성물질
JP2721805B2 (ja) * 1994-07-22 1998-03-04 日本バイエルアグロケム株式会社 新規ヘテロ環式化合物
DE19904310A1 (de) * 1999-01-28 2000-08-03 Bayer Ag Verfahren zur Herstellung heterocyclischer Verbindungen
MXPA02007060A (es) 2000-01-19 2003-01-28 Bayer Ag Procedimiento para la obtencion de compuestos heterociclicos.
CN1401646A (zh) * 2001-08-08 2003-03-12 南通江山农药化工股份有限公司 一种杀虫化合物及生产方法
EP3350172A1 (fr) 2015-09-15 2018-07-25 Bayer Cropscience LP Procédé pour la préparation de 2-cyanoimino -1,3-thiazolidine

Also Published As

Publication number Publication date
MX2018015178A (es) 2019-04-24
CN109311866A (zh) 2019-02-05
WO2017211594A1 (fr) 2017-12-14
TWI750181B (zh) 2021-12-21
KR102380911B1 (ko) 2022-03-30
US20210261536A1 (en) 2021-08-26
JP2019517535A (ja) 2019-06-24
US11161840B2 (en) 2021-11-02
TW201819373A (zh) 2018-06-01
CN109311866B (zh) 2022-12-09
BR112018075237B1 (pt) 2022-08-23
KR20190015339A (ko) 2019-02-13
IL263091B (en) 2021-06-30
IL263091A (en) 2018-12-31
JP6946354B2 (ja) 2021-10-06
BR112018075237A2 (pt) 2019-03-12

Similar Documents

Publication Publication Date Title
EP1856024B2 (fr) Procede de fabrication de biphenyls substitues
DE202007018473U1 (de) 9-Hydroxy-Risperidon (Paliperidon)
EP1616863A1 (fr) Procédé pour la préparation des composés aromatiques fluorés
EP1899337B1 (fr) Procede pour realiser des composes de 3,7-diaza-bicyclo[3.3.1]nonane
DE60035109T2 (de) Verfahren zur herstellung von thiamethoxam
EP2079705B1 (fr) Procédé de production de carbonates quaternaires
EP2212289B1 (fr) Procédé de préparation de dérivés de 2,2-difluoréthylamine par hydratation d'amides
DE3514450A1 (de) Verfahren zur herstellung von imidaten sowie neue arylsubstituierte imidate
DE102009022830A1 (de) Verbessertes Verfahren zum Herstellen von Diaminopyridinen
EP3464283A1 (fr) Procédé de préparation de composés hétérocycliques
EP0004623B1 (fr) Procédé pour la préparation d'amines aromatiques
WO1999065861A1 (fr) Procede de disubstitution symetrique et asymetrique d'amides d'acide carboxylique avec des organotitanates et des reactifs de grignard
EP0370325B1 (fr) Procédé pour la déshalogénation réductive de composés aromatiques
EP1252159B1 (fr) Procede de production de composes heterocycliques
DE60011427T2 (de) Verfahren zur herstellung von 2-pyridylpiperidin-derivaten
DE19904310A1 (de) Verfahren zur Herstellung heterocyclischer Verbindungen
EP3577105B1 (fr) Préparaton d'hydroxylamines aromatiques n-substituées
DE69924702T2 (de) Difluormethoxybenzolderivate und ihre verwendung als zwischenprodukte
DE19632643C1 (de) Katalysierte Kopplung von Arylmagnesiumhalogeniden und Bromarylcarbonsäureverbindungen zur Herstellung von Biphenylcarbonsäuren
EP1442010B1 (fr) Procede de production de biphenyl-4-carbonitrile
DE3534827A1 (de) Verfahren zur herstellung von 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridin
EP1675851B1 (fr) Procede pour produire des 3beta-aminonortropanes n-substitues
CH482712A (de) Verfahren zur Herstellung von 3-Amino-1,2,5-thiadiazolen
AT366059B (de) Verfahren zur herstellung von neuen phosphoniumimidazolverbindungen und von deren saeureadditionssalzen
DE1940704C3 (de) Verfahren zur Herstellung von 2-Mercaptoinosin

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200320

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230208

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230620